In summary, there is substantial evidence regarding the critical role of IGF-1/IGF-1R signaling in the progression of PCa, with studies reporting correlations of IGF-1/IGF-1R with tumor cell proliferation, Gleason score, metastatic disease progression, and clinical outcomes. The gene discussed is IGF1; the disease is neoplasm.